Fluorescein Sodium Active Pharmaceutical Ingredient (API) Supply

The contract pertains to the supply of bulk Fluorescein Sodium active pharmaceutical ingredient (API) specifically formulated to meet FDA, USP, and cGMP standards for use in diagnostic ophthalmic products. The material must be manufactured and tested under rigorous quality control protocols to ensure purity, potency, and consistency required for clinical diagnostics. The supply is designated as a subcontract under NAICS code 325412 and is being procured by the Department of Defense through its Medical Supply Chain Pharm FSA entity, with performance required at a designated location in Groton, Connecticut, ZIP 06340-4905. Proposals must be submitted by the response deadline of May 18, 2026, following the solicitation posted on May 12, 2026, with all deliverables expected to align with regulatory compliance and performance specifications critical to patient safety and diagnostic accuracy.